China Natural Medicine Industry Transformation & Upgrading Strategic Analysis Report, 2013-2017
Last Update:2014-04-28
Form of services:Book + (pdf or doc file) + CD
Send method:EMS 2-3 days for delivery
English Service:+86 0755 33220413
Chinese Service:+86 800-8306390 800-8306395
E-mail:service.en@qianzhan.com
Report price:$7900 Print: $7800 CD: $7800
This table of content is original, without written permission of Qianzhan, any unit or individual shall not use, copy, or transfer the reports.
Preface
Table of Content
Transformation and upgrading is an eternally immutable topic for any industry. And it is a strategic choice for enterprises to react to the environmental change. The natural medicine industry in China achieves a fast growth and some success, but it is still in the development and transformation period. We should notice that it is the only and inevitable choice for the industry to fasten enterprises’ strategic transformation and upgrading in order to improve the core competitiveness of the industry.
With the deepening medical system reform in China, the market competition at home and abroad for natural medicine corporations is fierce. Accordingly, all the corporations with the hope to seize the industry high ground by enhancing competitiveness through transformation and upgrading. In this situation, some corporations choose specialized operation to strengthen major product and advancing brands; some choose the business model of vertical integration and establish their own marketing networks and channels. On one hand, they want to provide services for their own products; on the other hand, they try to make profit by medicine wholesales and retailing. And there are some corporations who prefer diversification strategy in order to lower risks. These transformation and upgrading models gains some achievement in the case of some typical enterprises that greatly improve the managerial and administrative expertise and form a solid foundation for the long-term development.
We have a roundly indepth analysis on the transformation and upgrading model of natural medicine industry. Answers to the question of “how to transform” will be given while researches to the topic of “where to transform and what is the target” will be proposed too. We will help you to clear the industrial chain and optimize an industry with the biggest investment value around the industrial chain. We will detail information for you in a full range, which covers from the natural medicine planting industry that represents the traditional industry to brand chain drug-store industry, from natural functional food industry which means a homology of medicine and food to natural cosmeceutical, from natural medical toothpaste which represents the rise of national brand to natural medication which means leisure and health. In the meantime, we will provide a scientific selection method to settle down the confusion of “how to transform and choose a new industry” for corporations. It will help corporations to make a strategic choice of new industry entry in the aspect of industry attractiveness and corporations’ competitiveness.
For the natural medicine enterprises that choose to transform and upgrade, the management is an unavoidable question. Especially for the one choose the diversification strategy, the simple and efficient management is a key and significant factor for success. This report will provide a comprehensive development strategy in the aspects of transformation opportunity and approach selection, brand strategy, strategic management model, resource guarantee, and risks management.
Undoubtedly, promoting by social progress the natural medicine industry is undergoing a tide of transformation and upgrading. This report will be useful for you to understand what the reform brings to natural medicine development, natural medicine market and the whole medicine industry.
You can check the business strategies of NuSkin, ANZAG, TSUMURA&CO., LG Care, Nin Jiom Medicine Mfy (HK) Ltd. and other leading corporations. Meanwhile, you can also refer trend of Amway, Tomson, Merck and other transnational pharmaceuticals in the field of natural medicine. We will provide you a full and fast information platform that you can get the industry information you should know in this very time.
We will help you to evaluate the advantages, disadvantages and profitable opportunity during the industry transformation and upgrading by 2015. And you will have a clear view of many commercial opportunities after enterprises transformation and upgrading. We aim to help managers save time and provide useful assist by research, analysis and discussion.
This report will analyze the prospects and trend of the industry transformation and upgrading. And opportunities and challenges will be covered too. We detail the following aspects to help you understand the industry and potential.
--Market scale forecast and major constitutors of the global natural medicine industry in 2015.
--Development forecast of global leading natural medicine markets in 2015, including the United States, Germany, Japan, Korea and H.K. China.
--Global leading natural medicine corporations, competitive landscape and market potential in 2015.
--Four transformation and upgrading models for natural medicine industry, including specialized operation, vertical integration, relevant diversification and irrelevant diversification.
--Transformation and upgrading direction and successful cases study.
--The latest product trend of natural medicine industry, and enormous market in the industries of medicine, daily use chemicals, agricultural, animal husbandry and food industry.
--Opportunities, promoting and limited forces of relevant market from 2011 to 2015.
--Analysis on the enterprises’ development opportunities and challenges, and suggestions for natural medicine corporations to enter new markets.
Qianzhan Business Information Co., Ltd. Industry Research College
Research Team of Natural Medicine Industry
China Natural Medicine Industry Report" related reports »
- China Chemical Pharmaceutical Industry Market Monitoring Monthly Report, January
- Chinese Patent Medicine Industry Market Monitoring Monthly Report
- China Medicine Industry Market Monitoring Monthly Report
- China Chemical Pharmaceutical Industry Market Monitoring Monthly Report
- China Gallbladder and Liver Disease Medical Industry Market Forecast and Investment Strategy Report, 2013-2017
- China Diagnostic Reagent Industry Production & Marketing and Investment Forecast Report, 2013-2017
- China Cardiovascular System Drugs Industry Market Demand Forecast and Investment Strategy Planning, 2013-2017
- China Respiration System Chemical Medicine Industry Competitive Landscape and Leading Enterprise Research Report, 2013-2017
- Chinese Medicine Injection Industry Prospects and Investment Forecast Report, 2013-2017
- China Disinfection & Sterilization equipment Industry Production & Marketing Demand and Investment
- China Third-party Medical Diagnosis Industry Market Forecast and Investment Strategy Planning Report, 2013-2017
- China Pharmaceutical Excipients Industry Indepth Research and Investment Strategic Planning Report, 2013-2017
- China Drug Procurement and Agency Industry Report 2014-2018, Market Prospect and Investment Strategic Planning
- China Diabetes Medication Industry Analysis Report 2014-2018, Investment Forecast and Demand of Production and Sale
- China Radiation Protection Medicine Industry Report, Market Research and Development Prospect
- China Veterinary Medicine Industry Production & Marketing and Investment Forecast Report
- China Disease Prevention and Control Industry Report 2014-2018, Market Prospect and Investment Strategic Planning
- China In-Vitro Diagnosis Industry Indepth Research and Investment Strategy Planning Report, 2013-2017
- China Diagnostic Reagent Industry Production Marketing and Investment Forecast Report, 2013-2017
- China Dental Medical Industry Market Forward and Investment Strategy Report, 2013-2017
- China Penicillin Industry Research Report (2014-2018), Market Demand & Investment Forecast
- China Anesthetic Agent Industry Indepth Research and Investment Strategy Planning Report, 2013-2017
- China Marine Biological Medicine Industry Indepth Research and Investment Strategy Planning Report, 2013-2017
- China Antihypertensive Drug Industry Report (2014-2018), In-depth Research and Investment Strategic Planning
- China Herbal Pieces Processing Industry Production & Marketing Demand and Investment Forecast Report, 2013-2017
1. English Service: +86 0755 33220413
2. Chinese Service: +86 8008306390 8008306395
3. Mail Order: service.en@qianzhan.com
4. Online Order: Click "Order Now" button on this page
5. Purchase On-site: 19F Block A, First World Plaza, Hongli West Rd, Futian District, Shenzhen China
- 1. Please be aware of " Qianzhan " trademark, qianzhan has never used any third to sell reports, please make a phone call and purchase it directly.
- 2. You are warmly welcome to visit Qianzhan, and close transaction after confirmation.
- ·Energy and Environment»
- New Energy Natural Gas Energy Conservation Water Resources Coal Electricity Others
- ·Recreation and Sports»
- Education Advertisement Film and Television Publication Packing and Printing Sports Resort Hotel Catering Internet Animation Others Media
- ·Transport Logistics and Supporting»
- Water Transport Airport Road Transport Logistic Distribution Vehicle and Fittings Post-Market Others
- ·Medical and Health»
- Medical Device Biomedicine Medical Institution Healthcare and Nursing Medicine and Pharmacy Others
- ·Retail or FMCG»
- Retail Commercial Trade Food Beverage Dairy Product Seasoning Wine and Tobacco Cosmetics Cleaning Product Daily Necessities Others
- ·Real Estate and Construction»
- Real Estate Real Estate Intermediary Public Safety Construction Engineering Survey and Design Building Materials Housing Accomodation Others
- ·Mechanical Manufacturing»
- Precision Instrument Transport Instrument Electricity Supporting Equipment Special Equipment General Equipment Others
- ·New Chemical Material»
- Ink and Pigment Coating Chemical Fibres Synthetic Fibres Chemicals Industrial Chemicals Rubber Plastics Basic Chemicals Others
- ·Light Textile and Clothing»
- Luxury Jewelry Leather Raw Materials Shoes and Hats Clothing Textile Others
1. The copyright of this report is reserved by Qianzhan Business Information Co., Ltd. (Industry Research Institute of Qianzhan), the shipment and post-sale service is handled by the issue department of Qianzhan Business Information Co., Ltd. (Industry Research Institute of Qianzhan). The only copyright of all research report products of our company is reserved; we did not authorize any third party sales agent, if you are to purchase our report, please contact our customer service directly.
2. A limited of customers are offered with our reports with compensation; those reports are only for internal usage and are only for researching and analyzing purposes. We will not be responsible for any misunderstanding or legal issues caused by external usage or references with the report.
More>>
